Is Hemab Therapeutics Holdings, Inc. Common Stock (COAG) a Buy, Sell, or Hold?
NASDAQ : COAG
Hemab Therapeutics Holdings, Inc. Common Stock — Analyst Ratings
$48.06 USD
-$1.33 (-2.69%)
- Volume
- 150.69K
- Average Volume
- 350.38K
- Market Capitalization
- $96.54M
- P/E Ratio
- -20.63
- Dividend Yield
- 0.00%
- Price Target
- $50.00
- Year High
- $52.15
- Year Low
- $23.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.03
Analyst Consensus Summary
Consensus Rating
Sell
3 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-3.9%
vs Current Price
Price Target
$50.00
Average TargetPrice Target Range
Lowest Target
$36.00
33.5% UPSIDE
Average Target
$50.00
Median Estimate
Highest Target
$55.00
-12.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 3
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 3 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wedbush | David Nierengarten | $55 | $38.85 | 2026-07-13 08:08 AM | 41.6% |
| H.C. Wainwright | Emily Bodnar | $52 | $38.03 | 2026-07-13 06:05 AM | 36.7% |
| Wedbush | David Nierengarten | $42 | $25.89 | 2026-05-26 07:02 AM | 62.2% |
| Jefferies | Maury Raycroft | $39 | $25.89 | 2026-05-26 03:16 AM | 50.6% |
| Goldman Sachs | Richard Law | $36 | $25.89 | 2026-05-26 12:52 AM | 39.0% |